芪精消渴汤与二甲双胍联合治疗2型糖尿病的临床疗效
2018-12-21田苓珍
田苓珍
[摘要] 目的 分析2型糖尿病应用芪精消渴汤结合二甲双胍治疗的疗效。方法 选择该院2016年5月—2018年5月诊治的78例2型糖尿病患者,随机分成研究组(39例)和对照组(39例)。对照组使用二甲双胍治疗,研究组接受二甲双胍联合芪精消渴汤治疗,比较两组治疗效果。结果 研究组治疗后的有效率94.87%,明显高于对照组,差异有统计学意义(P<0.05);研究组HbAlc(6.51±0.93)%、2 hPG(8.46±1.21)mmol/L、FPG(6.51±1.53)mmol/L,优于对照组,差异有统计学意义(P<0.05)。结论 芪精消渴汤联合二甲双胍对2型糖尿病的疗效显著,可明显提升治疗效率,降低血糖水平。
[关键词] 二甲双胍;芪精消渴汤;2型糖尿病;疗效;血糖
[中图分类号] R259 [文献标识码] A [文章編号] 1672-4062(2018)08(b)-0077-02
Clinical Efficacy of Qijing Xiaoke Decoction Combined with Metformin in the Treatment of Type 2 Diabetes
TIAN Ling-zhen
West Pharmacy, Second People's Hospital of Junan County, Linyi, Shandong Province, 276600 China
[Abstract] Objective To analyze the efficacy of Qijing Xiaoke Decoction combined with metformin in type 2 diabetes. Methods A total of 78 patients with type 2 diabetes mellitus who were treated in the hospital from May 2016 to May 2018 were randomly divided into study group (39 cases) and control group (39 cases). The control group was treated with metformin, and the study group received metformin combined with Qijing Xiaoke Decoction to compare the therapeutic effects of the two groups. Results The effective rate of the study group was 94.87%, which was significantly higher than that of the control group,the differeent was statistically significant(P<0.05). The study group HbAlc (6.51±0.93)%,2 hPG(8.46±1.21)mmol/L,FPG(6.51±1.53)mmol/L,better than the control group,the differeent was statistically significant(P<0.05). Conclusion Qijing Xiaoke Decoction combined with metformin is effective in the treatment of type 2 diabetes, which can significantly improve the treatment efficiency and lower blood glucose levels.
[Key words] Metformin; Qijing Xiaoke Decoction; Type 2 diabetes; Efficacy; Blood glucose
2型糖尿病为常见的一种内分泌代谢紊乱疾病,患者表现为持续性高血糖,随着疾病发展,可引发糖尿病眼病、冠心病、中风等不良并发症,严重威胁患者的身心健康与生存质量[1]。临床治疗原则以控制血糖水平、改善临床症状、降低并发症出现为主[2]。该文于2016年5月—2018年5月旨在探析39例2型糖尿病患者予以二甲双胍与芪精消渴汤联合治疗的效果,现报道如下。
1 资料与方法
1.1 一般资料
选取该院接收的2型糖尿病患者78例,随机分为对照组和研究组,各39例,其中对照组男21例,女18例,年龄40~67岁,平均年龄(49.87±6.52)岁,病程2~10年,平均病程(5.47±1.23)年;研究组中男22例,女17例,年龄42~66岁,平均年龄(49.86±6.48)岁,病程3~11年,平均病程(5.49±1.25)年;两组基线资料差异无统计学意义(P>0.05),存在可比性。
1.2 方法
两组患者均先进行常规支持治疗,即指导患者正确的饮食习惯,以低脂、低盐食物为原则,忌食辛辣刺激性食物,并进行适量的运动训练。在此基础上对照组接受二甲双胍(国药准字H20044070,规格:0.5 g×60片)治疗,1.0 g/次,2次/d;研究组则给予芪精消渴汤……
